• WeedMD (WMD) has been added to the Horizons Marijuana Life Sciences Index ETF (HMMJ)
  • The company was added during HMMJ’s quarterly rebalancing
  • HMMJ is the first ETF to offer direct exposure to North American-listed stocks in the cannabis industry
  • WeedMD is a federally licensed producer and distributor of medical-grade cannabis
  • The Horizons Marijuana Life Sciences Index ETF (HMMJ) is up 0.46 per cent and is currently trading at C$11.83 per share
  • WeedMD (WMD) is up 1.61 per cent and is currently trading at C$0.315 per share

WeedMD (WMD) has been added to the Horizons Marijuana Life Sciences Index ETF (HMMJ).

The company was added during HMMJ’s quarterly rebalancing.

This follows the addition of WeedMD to the North American Marijuana Index, the underlying index of the HMMJ.

The Horizons Marijuana Life Sciences Index ETF is the first ETF to offer direct exposure to North American-listed stocks in the cannabis industry.

The ETF is passively managed and seeks to replicate the performance of the North American Marijuana Index, net of expenses.

The North American Marijuana Index selects from a universe of companies operating in one or more segments of the cannabis industry, including biopharmaceuticals, medical manufacturing, distribution and bio-products.

WeedMD is the parent company of WeedMD RX and Starseed Medicinal, license holders producing and distributing cannabis products for both the medical and adult-use markets.

The company owns and operates a 158-acre greenhouse, outdoor and processing facility in Strathroy, On, as well as a 26,000 sq. ft. processing facility in Aylmer, On specializing in cannabis extraction.

The company also maintains supply agreements with Shoppers Drug Mart and seven provincial distribution agencies where its adult-use brands Color Cannabis and Saturday are sold.

The Horizons Marijuana Life Sciences Index ETF (HMMJ) is up 0.46 per cent and is currently trading at C$11.83 per share as of 9:38 am ET.

WeedMD (WMD) is up 1.61 per cent and is currently trading at C$0.315 per share as of 9:30 am ET.

More From The Market Online

Tilray Brands seeks US$250M for U.S. cannabis expansion

Global cannabis stock Tilray Brands (TSX:TLRY) intends to raise up to US$250 million to fund its U.S. expansion plan.

The Market Online’s Weekly Cannabis Report – May 17, 2024

This international biopharmaceutical company revealed it has completed the retrospective observational real-world evidence study.

Avicanna finishes study of CBD cream’s use for rare skin disorder

Avicanna (TSX:AVCN) completes an observational study of its RHO Phyto-branded Ultra CBD topical cream on patients with epidermolysis bullosa.